A Phase I/III, multicenter, open-label trial of talimogene laherparepvec (T-VEC) in combination with pembrolizumab for the treatment of unresected, stage IIIb-IV melanoma (MASTERKEY-265)
Long, Georgina V, Dummer, Reinhard, Ribas, Antoni, Puzanov, Igor, Michielin, Olivier, VanderWalde, Ari, Andtbacka, Robert HI, Cebon, Jonathan, Fernandez, Eugenio, Malvehy, Josep, Olszanski, Anthony J,Volume:
3
Year:
2015
Language:
english
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1186/2051-1426-3-S2-P181
File:
PDF, 256 KB
english, 2015